Sjogren-Larsson syndrome

Advances in Experimental Medicine and Biology

Volumn 724, Issue , 2012, Pages 344-350

  Dutra, Lívia Almeida ^a   Braga Neto, Pedro ^a   Pedroso, José Luiz ^a   Povoas Barsottini, Orlando Graziani ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ETRETIN; RETINOID; ALDEHYDE DEHYDROGENASE; LONG CHAIN ALDEHYDE DEHYDROGENASE; LONG-CHAIN-ALDEHYDE DEHYDROGENASE;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DORFMAN CHANARIN SYNDROME; HISTOCHEMISTRY; HUMAN; HYPERKERATOSIS; ICHTHYOSIS; LIPID METABOLISM; MASS FRAGMENTOGRAPHY; MISSENSE MUTATION; MOLECULAR MODEL; MUTATIONAL ANALYSIS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PASSWELL SYNDROME; PHAKOMATOSIS; PHOTOPHOBIA; PRIORITY JOURNAL; REFSUM DISEASE; RETINA PIGMENT DEGENERATION; RUD SYNDROME; SCALP PRURITUS; SEIZURE; SJOEGREN LARSSON SYNDROME; SKIN BIOPSY; SKIN MANIFESTATION; SPASTICITY; SPECTROFLUOROMETRY; TAY SYNDROME; GENETICS; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW;

ALDEHYDE OXIDOREDUCTASES; HUMANS; MUTATION; SJOGREN-LARSSON SYNDROME;

EID: 84859501887     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-0653-2_26     Document Type: Article

References (28)

1. Dutra LA, Aquino CCH, Barsottini OGP. Sjogren-Larsson syndrome: case report and review of neurologic abnormalities and ichthyosis. The Neurologist 2009; 15:332-334.
2. Rizzo WB. Sjogren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency. Mol Genet Metab 2007; 90:1-9.
3. Sjögren T. Oligophrenia combined with congenital ichthyosiform erythrodermia, spastic syndrome and macular-retinal degeneration. Acta Genetica 1956; 6:80-91.
4. Sjögren T, Larsson T. Oligophrenia in combination with congenital ichthyosis and spastic disorders. Acta PsychiatrNeurol Scand 1957; 32(Suppl113):1-113.
5. Theile U. Sjögren-Larsson syndrome. Oligophrenia-ichthyosis-di- tetraplegia. Humangenetik 1974; 22:91-118.
6. Haug S, Braun-Falco M. Restoration of fatty aldehyde dehydrogenase deficiency in Sjogren-Larsson syndrome. Getie Ther 2006; 13:1021-1026.
7. Rizzo WB, Carney G, Lin Z. The molecular basis of Sjogren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene. Am J Hum Genet 1999; 65:1547-1560.
8. Liden S, Jagell S. The Sjogren-Larsson syndrome. Int J Dermatol 1984; 23:247-253.
9. Rizzo WB, S'Aulis D, Jennings MA et al. Ichthyosis in Sjogren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion. Arch Dermatol Res 2010; 302(6):443-451.
10. Willemsen MA, Rotteveel JJ, van Domburg PH et al. Preterm birth in Sjogren-Larsson syndrome. Neuropediatrics 1999; 30:325-327.
11. Willemsen MA, IJlst L, Steijlen PM et al. Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjogren-Larsson syndrome. Brain 2001; 124:1426-1434.
12. Jagell S, Heijbel J. Sjögren-Larsson syndrome: physical and neurological features. A survey of 35 patients. Helv Paediatr Acta 1982; 37:519-530.
13. Van Mieghem F, Van Goethem JW, Parizel PM et al. MR of brain in Sjogren-Larsson syndrome. Am J Neuroradiol 1997; 18:1561-1563.
14. Willemsen MAAP, van der Graaf M, van der Knaap MS et al. MR imaging and proton MR spectroscopic studies in Sjogren-Larsson syndrome: characterization of the leukoencephalopathy. AJNR 2004; 25:649-657.
15. Rizzo WB, Carney G. Sjögren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2). Hum Mutat 2005; 26(1):1-10.
16. Rogers GR, Markova NG, De VL et al. Genomic organization and expression of the human fatty aldehyde dehydrogenase gene (FALDH). Genomics 1997; 39:127-135.
17. Chang C, Yoshida A. Human fatty aldehyde dehydrogenase gene (ALDH10): organization and tissue-dependent expression. Genomics 1997; 40:80-85.
18. Ashibe B, Motojima K. Fatty aldehyde dehydrogenase is up-regulated by polyunsaturated fatty acid via peroxisome proliferator-activated receptor alpha and suppresses polyunsaturated fatty acid-induced endoplasmic reticulum stress. FEBS J 2009; 276(23):6956-6970.
19. Cakirer S, SavasMR. Infantile refsum disease: serial evaluation with MRI. Pediatr Radiol 2005; 35:212-215.
20. Wanders RJ, Jansen GA, Skjeldal OH. Refsum disease, peroxisomes and phytanic acid oxidation: a review. J Neuropathol Exp Neurol 2001; 60:1021-1031.
21. Duzovali O, Ikizoglu G, Turhan AH et al. Dorfman-Chanarin syndrome: a case with hyperlipidemia. TurkJ Pediatr 2006; 48:263-265.
22. Jorizzo JI, Crounse RG, Wheeler CE Jr. Lamellar ichthyosis, dwarfism, mental retardation and hair shaft abnormalities.JAmAcadDermatol 1980; 2:309-317.
23. Happle R, Traupe H, Grobe H et al. The Tay syndrome (congenital ichthyosis with trichothiodystrophy). Eur J Pediatr 1984; 141:147-152.
24. Marxmiller J, Trenkle I, Ashwal S. Rud syndrome revisited: ichthyosis, mental retardation, epilepsy andhypogonadism. Dev Med Child Neurol 1985; 27:335-343.
25. Andria G, Ballabio A, Parenti G et al. Steroid sulphatase deficiency is present in patients with the syndrome 'ichthyosis and male hypogonadism' and with 'Rud syndrome'. J Inherit Metab Dis 1984; 7(Suppl2):159-160.
26. Passwell J, Ziprkowskin L, Katzelson D et al. A syndrome characterized by congenital ichthyosis with atrophy, mental retardation, dwarfism and generalized amino aciduria. J Pediatr 1973; 82:466-471.
27. Muhammed K, Safia B. Passwell syndrome. Indian J Dermatol Venereol Leprol 2003; 69:180-181.
28. Gånemo A, Jagell S, Vahlquist A. Sjogren-Larsson syndrome: a study of clinical symptoms anddermatological treatment in 34 Swedish patients. Acta Derm Venereol 2009; 89(1):68-73.